Dynlrb1tm1c(EUCOMM)Wtsi/Dynlrb1tm1c(EUCOMM)Wtsi Runx3tm6(EGFP/cre)Yg/Runx3+
involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6N
|
abnormal gait |
J:292124
|
abnormal motor coordination/balance |
J:292124
|
abnormal proprioceptive neuron morphology |
J:292124
|
decreased locomotor activity |
J:292124
|
impaired balance |
J:292124
|
limb grasping |
J:292124
|
normal
nervous system phenotype |
J:292124
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Runx1tm1Toku/Runx1tm1Toku Runx3tm1Itan/Runx3tm1Itan Tg(Cd4-cre)1Cwi/0
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/2
|
abnormal interferon secretion |
J:131081
|
increased CD4-positive, alpha-beta T cell number |
J:131081
|
Runx1tm1Tani/Runx1tm1Tani Runx3tm1Itan/Runx3tm1Itan Tg(Cd4-cre)1Cwi/?
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
|
decreased CD8-positive, alpha-beta T cell number |
J:125959
|
Runx1tm1Toku/Runx1+ Runx3tm1Itan/Runx3tm1Itan Tg(Cd4-cre)1Cwi/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
|
decreased CD8-positive, alpha-beta T cell number |
J:131081
|
Runx1tm1Toku/Runx1tm1Toku Runx3tm1Itan/Runx3+ Tg(Cd4-cre)1Cwi/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
|
decreased CD4-positive, alpha-beta T cell number |
J:131081
|
decreased CD8-positive, alpha-beta T cell number |
J:131081
|
Runx1tm1Toku/Runx1tm1Toku Runx3tm1Itan/Runx3tm1Itan Tg(Cd4-cre)1Cwi/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
|
decreased CD4-positive, alpha-beta T cell number |
J:131081
|
decreased CD8-positive, alpha-beta T cell number |
J:131081
|
Runx2tm1Mjo/Runx2+ Runx3tm1Yg/Runx3tm1Yg
involves: 129S1/Sv * 129X1/SvJ * ICR
|
delayed bone ossification |
J:224290
|
postnatal lethality, incomplete penetrance |
J:224290
|
Runx2tm1Mjo/Runx2+ Runx3tm3Yg/Runx3tm3Yg Tg(Col1a1-cre)1Kry/0
involves: FVB/N
|
decreased body height |
J:224290
|
decreased body size |
J:224290
|
Runx3tm1.1Itok/Runx3tm1.1Itok Trp53tm1Brn/Trp53tm1Brn Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
involves: 129P2/OlaHsd * C57BL/6 * CD-1
|
decreased osteosarcoma incidence |
J:319454
|
increased tumor-free survival time |
J:319454
|
Runx3tm1Itan/Runx3+ Trp53tm1Brn/Trp53tm1Brn Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
involves: 129P2/OlaHsd * C57BL/6 * CD-1
|
decreased osteosarcoma incidence |
J:319454
|
increased tumor-free survival time |
J:319454
|
Runx3tm1Itan/Runx3tm1Itan Trp53tm1Brn/Trp53tm1Brn Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
involves: 129P2/OlaHsd * C57BL/6 * CD-1
|
premature death |
J:319454
|